2002 Saab 9-3 Se Hatchback 4-door 2.0l One Owner And No Reserve on 2040-cars

Auto blog

Rally legend Erik Carlsson dies at 86

The motorsports world has lost a legend with the passing of famous rally driver Erik Carlsson at the age of 86. If you've ever seen a photo of a vintage Saab sliding around a corner or blasting through tree-lined roads, there was a good chance that Carlsson was behind the wheel. The man was so tied to the Swedish auto brand that he earned the nickname Mr. Saab. Carlsson experienced his greatest competition success in the late '50s and early '60s when he scored victories in premier events like the Monte Carlo Rally (pictured above). Among his more impressive performances were consecutive wins in '60, '61, and '62 Britain's RAC Rally. His three-cylinder, 750cc Saab 96 wasn't insanely powerful, but Carlsson made it a monster in the world of rallying. In 2010, Saab named a special edition 9-3 after him and honored his victory at the RAC Club in London. Beyond being impressive behind the wheel of a rally car and a longtime Saab brand ambassador, the driver had a habit of rolling his car during competition to earn the moniker "Carlsson On The Roof." According to Classic and Sports Car, he also wrote the book The Art and Technique of Driving that detailed his left-foot braking method, and it was co-authored with his wife, fellow racing driver Pat Moss. Our condolences go out to Carlsson's friends and family.

Turkey buys rights to Saab 9-3 for domestic car

Just in time for Halloween, a Saab is rising from the dead. National Electric Vehicle Sweden, which controls the Swedish automaker, is selling the intellectual property rights for the second-generation 9-3 to the Scientific and Technological Research Council of Turkey (TUBITAK). This government-supported agency intends to turn the sedan into the "Turkish National Car," according to NEVS. Using the aging 9-3 as a backbone, Turkey intends to strengthen the nation's auto industry by producing an extended-range electric vehicle by 2020, Daily Sabah reports. The goal is for 85-90 percent of the components to come from the country. "From design to production, Turkey will be the center for all parts and processes regarding the first domestically produced car," Interim Science, Industry and Technology Minister Fikri Isik said to Daily Sabah. TUBITAK considered developing its own vehicle from scratch but calculated at least $1 billion in costs. Without going into specific detail, Isik said that buying the rights to the existing Saab turned out to be a better option. Despite having sold the 9-3 IP, NEVS is signing on to help with a business plan and to create the necessary supply and distribution chains for the EV. NEVS previously tried to revive the 9-3 itself by briefly continuing production and attempting to launch an electric version. Earlier this year, it partnered with Dongfeng to develop green vehicles. The company has been beset with financial problems, embroiled in a seemingly interminable post-bankruptcy reorganization progress. NEVS has been chosen by TUBITAK as its partner for developing a Turkish National Car TUBITAK, (the Scientific and Technological Research Council of Turkey) which has been assigned to develop "Turkish National Car" and realize this important mission, has chosen National Electric Vehicle Sweden AB, Nevs, as the industrial partner for the project. The cooperation has started in June 2015 between Nevs and TUBITAK and future industrial synergies in terms of development and manufacturing shall be generated with this cooperation. In the short term perspective this cooperation shall put Nevs' assets to work and shall give Turkey quick access to extensive automotive knowledge and experience. Nevs shall also provide its know-how in the developing of the business plan and establishing of the supply and distribution chains to TUBITAK.

NEVS, the company that took over Saab, gets new majority owner

Chinese real estate conglomerate Evergrande Group, a key investor behind troubled electric vehicle startup Faraday Future, has acquired a 51 percent stake in NEVS. That's the Chinese-backed Swedish electric vehicle company that purchased the assets of Saab out of bankruptcy in 2012. The investment by subsidiary Evergrande Health Industry Group was valued at the equivalent of $930 million and is expected to help NEVS develop new EVs. Evergrande said it paid the first installment of $430 million on Jan. 15, with the remainder due by the end of the month. The remaining 49 percent stake is controlled by a holding company controlled by NEVS founder Kai Johan Jiang. "It means that NEVS will get a financial (sic) strong main owner who is very interested in developing our vision about green mobility transport solutions for the future," NEVS CEO Stefan Tilk said in a statement. NEVS, short for National Electric Vehicle Sweden, owns production facilities in Trollhattan, Sweden, and Tianjin, China, with another under construction in Shanghai. In late 2017 the company launched what apparently was limited production of the 9-3 EV, an electric vehicle based — you guessed it — on the old Saab 9-3 platform. The company now says it will be built in Tianjin starting later this year, with components coming from Trollhattan. It boasts a 186-mile range, in-car WiFi and a cabin air filter for the notoriously smoggy Chinese air. It also showed a battery-electric 9-3X concept at CES Asia in 2017, which is likely to be its next model pegged for production. The South China Morning Post, citing local media reports, says two of NEVS' models meet the standards for mass production in China. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. Definitely the best promotional video we've ever seen. Evergrande Health first came to Faraday Future's rescue back in 2017 with a promised $2 billion investment, but the two sides later went into arbitration in Hong Kong over a dispute about money following the first infusion of $800 million, leading the automaker to cut staff and wages last year, casting the future of FF into doubt. At the end of 2018, Faraday announced it had entered into a new restructuring agreement with an Evergrande Health subsidiary that sees them end litigation and jettison the previous investment agreement, taking Evergrande's investment in the company to 32 percent.